Aadi Bioscience to Report Fourth Quarter and Full-Year 2024 Results and Corporate Update
Aadi Bioscience (Nasdaq: AADI) has announced it will host a webcast on Wednesday, March 19, 2025 to discuss its fourth quarter and full-year 2024 financial results along with recent corporate updates.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Aadi Bioscience (Nasdaq: AADI) has announced it will host a webcast on Wednesday, March 19, 2025 to discuss its fourth quarter and full-year 2024 financial results along with recent corporate updates. The financial results and updates will be accessible through the company's website under the 'Investors & News' section at aadibio.com.
Details
News Market Reaction – AADI
The recorded move for AADI in the trading session of this news was +2.59%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
About Aadi Bioscience
Aadi is a precision oncology company with a vision to make bold choices in applying technology to efficiently deliver improved precision oncology therapies for people living with difficult-to-treat cancers.
Contact:
IR@aadibio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/aadi-bioscience-to-report-fourth-quarter-and-full-year-2024-results-and-corporate-update-302401635.html
SOURCE Aadi Bioscience
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.